The global animal healthcare market is valued at USD 148.0 billion in 2026 and is projected to reach USD 250.4 billion by 2036, expanding at a CAGR of 5.4% from 2026 to 2036. The market was valued at USD 140.4 billion in 2025. Growth is being supported by increasing demand for animal health management, livestock productivity, disease prevention, veterinary care, and feed-based health solutions. Regulatory developments are also shaping product adoption, particularly in developed markets. In the European Union, Regulation 2019/6 on veterinary medicinal products is supporting compliance investment and encouraging the adoption of alternatives to conventional antibiotic-based approaches.
Global Segment Leaders
- Feed Additives – 30.0% share: Feed Additives leads the product type segment, supported by established procurement patterns and growing demand for animal nutrition, productivity, and health management solutions.
- Production Animals – 70.0% share: Production Animals dominates the animal type segment because livestock health management remains a major commercial requirement across poultry, cattle, swine, dairy, and other production systems.
- Livestock Health: Livestock health represents a major application area, supported by the need to maintain animal productivity, prevent disease outbreaks, and improve herd health.
- Disease Prevention: Disease prevention remains an important demand area as producers and veterinary organizations focus on reducing health risks and maintaining animal populations.
- Companion Animal Health: Companion animal healthcare continues to expand as pet ownership, veterinary spending, and demand for pharmaceuticals and preventive care increase across major markets.
Country-Level Performance
- South Korea – 4.2% CAGR: South Korea is projected to record the highest growth among the profiled countries. Companion animal population growth is increasing demand for veterinary pharmaceuticals and nutrition products, while livestock modernization is supporting procurement of feed additives and animal health products. Government investment in veterinary infrastructure is also strengthening disease prevention and surveillance programs.
- European Union – 3.9% CAGR: The European Union is supported by veterinary regulatory compliance, rising companion animal healthcare expenditure, and measures aimed at reducing antibiotic use. Regulation 2019/6 is encouraging investment in compliant veterinary medicinal products and alternative feed health solutions.
- UK – 3.8% CAGR: The UK market is benefiting from increasing household expenditure on pet healthcare, consolidation among veterinary practices, and livestock welfare regulations. These factors are supporting demand for premium companion animal products and health management solutions for dairy and sheep production.
- USA – 3.7% CAGR: The USA is supported by a large companion animal healthcare market, veterinary clinic expenditure on pharmaceuticals and diagnostics, and continued investment in health management across poultry, cattle, and swine production.
- Japan – 2.9% CAGR: Japan is expected to record the slowest growth among the profiled countries. Aging companion animals are increasing veterinary care requirements per pet, while declining production animal populations are being partly offset by higher per-animal healthcare spending and premiumization.
Regional Context
South Korea represents the fastest-growing country market among those profiled, with growth supported by companion animal population expansion, livestock modernization, and government investment in veterinary infrastructure. The European Union and UK form the next growth tier, where regulatory requirements, companion animal healthcare spending, livestock welfare standards, and alternative feed health products are shaping demand.
The USA represents a mature but steadily expanding market, supported by established veterinary infrastructure, strong companion animal spending, and health management requirements across livestock industries. Japan is also a mature market, with relatively slower growth reflecting demographic changes in production animals, although rising healthcare spending per companion and production animal continues to support market value.
The full report covers North America, Latin America, Europe, East Asia, South Asia and Pacific, and the Middle East and Africa, spanning 30+ countries.
Competitive Landscape
The competitive landscape includes Zoetis Inc., Boehringer Ingelheim Animal Health, Merck Animal Health (MSD Animal Health), Elanco Animal Health Incorporated, and Ceva Santé Animale. Leading companies compete through broad product portfolios, established distribution networks, regulatory capabilities, clinical evidence, geographic coverage, and relationships with veterinary and institutional purchasers.
In 2025, Zoetis expanded its animal healthcare portfolio through innovations including Lenivia for canine osteoarthritis pain and additional vaccine offerings. During 2025, major players including Zoetis and Merck Animal Health also invested in manufacturing capacity expansion and acquisitions to strengthen supply chains and support demand for companion animal and livestock healthcare products.
Regulatory approval requirements, clinical evidence, manufacturing capabilities, and customer access remain important barriers for new entrants. Established companies with broad portfolios and integrated distribution networks continue to compete across both production animal and companion animal healthcare markets.
Explore More Related Studies Published by FMI Research:
Business Impact
FMI helps organizations transform market complexity into strategic clarity, enabling leadership teams to identify growth opportunities faster, optimize resource allocation, strengthen competitive positioning, and make high-stakes business decisions with confidence.
To explore how FMI Custom Research can support your strategic priorities, please connect with our team at – sales@futuremarketinsights.com
About Future Market Insights (FMI)
Future Market Insights is a leading provider of market intelligence, consulting services, and syndicated research reports. FMI delivers actionable insights across food and beverage, healthcare, consumer goods, biotechnology, chemicals, industrial products, and emerging technologies, helping organizations identify growth opportunities and make informed strategic decisions in evolving global markets.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
Why FMI: https://www.futuremarketinsights.com/why-fmi
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
